Institutional investors purchased a net $14.6 thousand shares of RDHL during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 15.99% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PEILIM PORTFOLIO MANAGEMENT CO L... Bought 101.7 Thousand shares of Redhill Biopharma Ltd
D. A. DAVIDSON & CO. Bought 26.5 Thousand shares of Redhill Biopharma Ltd
FRED ALGER MANAGEMENT, INC. Bought 6.0 Thousand shares of Redhill Biopharma Ltd